| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |